Atida has completed a structuring and placement
Atida has completed a structuring and placement in the private equity fund Europe Pharma Online.
Atida is an online health company that is transforming the landscape of health and well-being across Europe. With online pharmacies and parapharmacies across nine countries and more than 4,000 active customers, Atida is on a mission to help Europeans make better decisions about their health by providing a trusted and personalized health ecosystem that caters to both proactive and curative needs.
Oaklins’ team in Chile acted as the structuring and placement agent in the private equity fund Europe Pharma Online.
Sprechen Sie mit dem Deal-Team
Transaktionen
Bolster Investment Partners hat eine Mehrheitsbeteiligung an Eternal Sun erworben
Bolster Investment Partners, eine in den Niederlanden ansässige Investmentfirma, hat eine Mehrheitsbeteiligung an Eternal Sun, einem weltweit führenden Technologieunternehmen für hochentwickelte Solarmodul-Testsysteme, von ABN AMRO Sustainable Impact Fund, einem privaten Impact Fund mit Sitz in den Niederlanden, und Vermec, einer in Belgien ansässigen Investmentfirma, erworben.
Mehr erfahrenCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahren